Skip to main content
Fairchem Organics Limited logo

Fairchem Organics Limited — Investor Relations & Filings

Ticker · FAIRCHEMOR ISIN · INE0DNW01011 LEI · 254900MLJRLNO00M6M52 BSE.NS Manufacturing
Open in API
Filings indexed 343 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS FAIRCHEMOR

About Fairchem Organics Limited

https://fairchem.in/

Fairchem Organics Limited specializes in the manufacturing of high-quality oleochemicals and nutraceuticals. The company primarily processes waste products and by-products from the vegetable oil refining industry, such as fatty acid distillates, to produce value-added chemicals. Its core product portfolio includes Dimer Acid, Linoleic Acid, Monomer Acid, and Distilled Fatty Acids, which serve diverse applications in the paints, printing inks, adhesives, and resins sectors. Additionally, the company is a significant producer of natural Vitamin E (Tocopherols) and Sterols, catering to the pharmaceutical, cosmetic, and food industries. By utilizing sustainable sourcing and advanced processing technologies, Fairchem Organics Limited maintains a strong market position in the production of specialty chemicals derived from renewable resources.

Recent filings

Filing Released Lang Actions
Please find attached herewith the Secretarial Compliance Report for F.Y. 2025-26
Regulatory Filings Classification · 92% confidence The document is a Secretarial Compliance Report prepared under Regulation 24A of SEBI (LODR) Regulations, 2015 by the company secretary and filed with stock exchanges. It is an officer’s attestation/certification of corporate governance and statutory compliance, rather than a full financial report or earnings release. Under the Certification Rule, such compliance certificates are classified as Regulatory Filings (RNS) rather than the underlying report type.
2026-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Fairchem Organics Limited for the quarter and financial year ended March 31, 2026. It includes detailed financial highlights, management commentary, and a Q&A session with investors. The text explicitly mentions it is a transcript of the earnings concall, which matches the definition of a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial discussion and management outlook, confirming it is not just an announcement or summary but the full transcript of the call.
2026-05-09 English
Please find attached herewith transcript of audio recording of Earnings Concall on Audited Financial Results for the Quarter and Year Ended March 31, 2026
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held by Fairchem Organics Limited for the quarter and financial year ended March 31, 2026. It includes detailed financial highlights such as revenue, EBITDA, net profit, volume sold, and discussions on business outlook, operational performance, and market conditions. The presence of a Q&A session with investors further confirms this is a full transcript of an earnings call. The document references the audited financial results for the quarter and year but is itself the transcript of the call discussing those results, not the financial report or announcement of the report. Therefore, the appropriate classification is Call Transcript (CT).
2026-05-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a submission to stock exchanges regarding the audio recording of an earnings call for the quarter and year ended March 31, 2026. It references Regulation 30 and SEBI (LODR) Regulations, which govern disclosures. The document provides a link to the audio recording of the earnings call but does not contain the transcript or detailed financial data itself. The length is short (1532 characters), and it is essentially an announcement of the earnings call recording availability, not the call transcript or financial report itself. Therefore, it should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the earnings call recording, not the transcript or report itself.
2026-05-07 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation Q4|12M FY26' and is addressed to stock exchanges referencing SEBI (LODR) Regulations, 2015, indicating a regulatory filing context. It contains detailed financial and operational highlights for the quarter and full fiscal year ending March 31, 2026, including revenue, EBITDA, PBT, PAT, margins, and comparative year-on-year data. The content is a presentation format with business overview, manufacturing process, product portfolio, competitive advantages, ESG initiatives, governance, and detailed quarterly financial performance. The document length is 15,000 characters, which is substantial and contains actual financial data and analysis, not just an announcement or summary. Therefore, it is a detailed earnings presentation document rather than a brief earnings release or a regulatory announcement. According to the filing definitions, this fits best under 'Investor Presentation (IP)' as it is a detailed presentation for investors focusing on financials, strategy, and market position, specifically for the quarter and full year ended FY26.
2026-05-07 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including audited financial results for the quarter and year ended March 31, 2026, with line items such as total income, net profit before and after tax, comprehensive income, equity capital, and earnings per share. It references approval by the Board of Directors and publication in a newspaper as per SEBI regulations. The document is lengthy (15,000 characters) and includes substantive financial data, not just an announcement or certification. The presence of quarterly and annual audited financial results with detailed figures indicates this is a financial report rather than a mere announcement or regulatory filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR) because it includes quarterly and year-end audited financial results, which are comprehensive financial reports for periods shorter than a full fiscal year (quarterly) and the year-end results. It is not a full Annual Report (10-K) as it is an extract of financial results, not a full annual report document. It is not an Earnings Release (ER) because it contains detailed financial data, not just highlights. It is not an Audit Report (AR) because it is not a standalone audit opinion document. Hence, the classification is IR with high confidence.
2026-05-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.